RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/2906E4DA553A2CBE83D1607562445DA6D32E2F99A4AC12FF1ADA85EEA5812A0807698A203F468C4A7D973CED5D84511Chttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2906E4DA553A2CBE83D1607562445DA6D32E2F99A4AC12FF1ADA85EEA5812A0807698A203F468C4A7D973CED5D84511Chttp://www.w3.org/2000/01/rdf-schema#comment"KCNQ activation decreased seizure latency by >/=50% in Kcnq1 strain mice but had no effect in the Kcna1 strain. However in simultaneous EEG and ECG recordings KCNQ activation significantly reduced spontaneous seizure frequency in Kcna1-/- mice by ~60%. In Kcnq1 mice KCNQ activation produced adverse cardiac effects including profound bradycardia and abnormal increases in heart rate variability and AV conduction blocks."xsd:string
http://purl.uniprot.org/uniprot/#_67CBB4522F64D1207D7E848FD5909439A5F8A4BC0E86A25D326E217788ACF39B04139ECC1A86376B70541A531499532Ahttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/2906E4DA553A2CBE83D1607562445DA6D32E2F99A4AC12FF1ADA85EEA5812A0807698A203F468C4A7D973CED5D84511C
http://purl.uniprot.org/uniprot/P16388http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/2906E4DA553A2CBE83D1607562445DA6D32E2F99A4AC12FF1ADA85EEA5812A0807698A203F468C4A7D973CED5D84511C
http://purl.uniprot.org/uniprot/#_P16388-mappedCitation-29265344http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/2906E4DA553A2CBE83D1607562445DA6D32E2F99A4AC12FF1ADA85EEA5812A0807698A203F468C4A7D973CED5D84511C